2-(3-4-dimethoxyphenyl)-1-(5-methoxy-2-2-dimethyl-2h-chromen-6-yl)ethanone and Neoplasms

2-(3-4-dimethoxyphenyl)-1-(5-methoxy-2-2-dimethyl-2h-chromen-6-yl)ethanone has been researched along with Neoplasms* in 2 studies

Reviews

1 review(s) available for 2-(3-4-dimethoxyphenyl)-1-(5-methoxy-2-2-dimethyl-2h-chromen-6-yl)ethanone and Neoplasms

ArticleYear
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Hsp90 is one of the most important chaperones involved in regulating the maturation of more than 300 client proteins, many of which are closely associated with refractory diseases, including cancer, neurodegenerative diseases, and viral infections. Clinical Hsp90 inhibitors bind to the ATP pocket in the N-terminal domain of Hsp90 and subsequently suppress the ATPase activity of Hsp90. Recently, with the increased understanding of the discrepancies in the isoforms of Hsp90 and the modes of Hsp90-co-chaperone-client complex interactions, some new strategies for Hsp90 inhibition have emerged. Novel Hsp90 inhibitors that offer selective suppression of Hsp90 isoforms or specific disruption of Hsp90-co-chaperone protein-protein interactions are expected to show with satisfactory efficacy and safety profiles. This review summarizes the recent progress in Hsp90 inhibitors. Additionally, Hsp90 inhibitory strategies are emphasized in this review.

    Topics: Animals; Antineoplastic Agents; Autoimmune Diseases; Benzoquinones; Forecasting; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Molecular Chaperones; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary

2020

Other Studies

1 other study(ies) available for 2-(3-4-dimethoxyphenyl)-1-(5-methoxy-2-2-dimethyl-2h-chromen-6-yl)ethanone and Neoplasms

ArticleYear
Design, synthesis, and biological evaluation of truncated deguelin derivatives as Hsp90 inhibitors.
    European journal of medicinal chemistry, 2019, Apr-01, Volume: 167

    A series of novel B and C-rings truncated deguelin derivatives have been designed and synthesized in the present study as heat shock protein 90 (Hsp90) inhibitors. The synthesized compounds exhibited micromolar antiproliferative potency toward a panel of human cancer cell lines. Their structure-activity relationships (SARs) were investigated in a systematic manner. Compound 21c was identified to have high Hsp90 binding potency (60 nM) and caused degradation of client proteins through ubiquitin proteasome system. Further biological studies showed that compound 21c induced a dose-dependent S and G2-phase cell cycle arrest on human breast cancer MCF-7 cells. Flow cytometry and Western blot analyses confirmed that compound 21c caused apoptosis of MCF-7 cells. In addition, compound 21c showed much potent inhibition on the migration and invasion of MCF-7 cells. Taken together, these results suggest that 21c might be a promising lead compound for further development of Hsp90 inhibitors.

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Proteasome Endopeptidase Complex; Rotenone; Structure-Activity Relationship

2019